000
| 01131nam##2200277za#4500 |
---|
001 | 9.615261 |
---|
003 | CaOODSP |
---|
005 | 20210615101040 |
---|
007 | ta |
---|
008 | 150406|2000||||xxc||||| f|0| 0 eng|d |
---|
020 | |a0-662-29194-8 |
---|
040 | |aCaOODSP|beng |
---|
043 | |an-cn--- |
---|
086 | 1 |aH42-2/67-18-2000E |
---|
110 | 1 |aCanada. |bHealth Products and Food Branch. |
---|
245 | 10|aViral safety evaluation of biotechnology products derived from cell lines of human or animal origin / |cIssued by the International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use. |
---|
260 | |aOttawa - Ontario : |bHealth Canada. |c2000. |
---|
300 | |aiii, 32p. ; |c28 cm. |
---|
490 | 1 |aGuidance for industry|vICH Topic Q5A |
---|
563 | |aLoose-leaf |
---|
590 | |a01-08|b2001-02-23 |
---|
690 | 07|aBiotechnology|2gcpds |
---|
690 | 07|aContamination|2gcpds |
---|
690 | 07|aBiochemical products|2gcpds |
---|
776 | 0#|tViral safety evaluation of biotechnology products derived from cell lines of human or animal origin |w(CaOODSP)9.573957 |
---|
830 | #0|aGuidance for industry ;|vICH Topic Q5A|w(CaOODSP)9.514730 |
---|